Crossmark

Repositioning therapeutics for COVID-19: virtual screening of the potent synthetic and natural compounds as SARS-CoV-2 3CLpro inhibitors

Published Online: 2021-03-26

Published Print: 2021-10

Authors

Sattari, Ahmad

Ramazani, Ali https://orcid.org/0000-0003-3072-7924
Aghahosseini, Hamideh
Funding

Funding for this research was provided by:

Iran National Science Foundation
License Information

Text and Data Mining valid from 2021-03-26

Version of Record valid from 2021-03-26
More Information

Article History

Received: 31 October 2020

Accepted: 1 March 2021

First Online: 26 March 2021

Declarations

:

: Authors declare that they have no conflict of interest.

: The authors confirm that the data supporting the findings of this study are available within the article and/or its supplementary materials.

Free to read: This content has been made available to all.

Document is current